[EN] COMPOUNDS, COMPOSITIONS, AND METHODS<br/>[FR] COMPOSÉS, COMPOSITIONS ET PROCÉDÉS
申请人:DENALI THERAPEUTICS INC
公开号:WO2022109268A1
公开(公告)日:2022-05-27
The present disclosure relates generally to small molecule modulators of NLR Family Pyrin Domain Containing 3 (NLRP3), or a pharmaceutically acceptable salt, isotopically enriched analog, stereoisomer, mixture of stereoisomers, or prodrug thereof, methods of making and intermediates thereof, and methods of using thereof.
We herein report an Ir-catalyzed enantioselective C(sp3)-H borylation of cyclopropanecarboxamides using a chiral bidentate boryl ligand for the first time. A variety of substrates with α-quaternary carbon centers could be compatible in this reaction to provide β-borylated products with good to excellent enantioselectivities. We have also demonstrated that the borylated products can be used as versatile
我们在此报告了首次使用手性双齿硼酸配体对环丙烷甲酰胺进行 Ir 催化的对映选择性 C(sp3)-H 硼酸化。具有 α-季碳中心的多种底物可以在该反应中相容,以提供具有良好至优异对映选择性的 β-硼酸化产物。我们还证明,硼酸化产物可用作多功能前体,参与 CB 键的立体有择转化,包括合成生物活性化合物 Levomilnacipran。